Search Results - "Gad, A.Z."

Immunotherapy: MODULATION OF CD6 SPLICE VARIANTS CONTROLS CAR T CELL ACTIVATION by Morris, J., Gad, A.Z., Godret-Miertschin, L., Fleischmann, R., Salsman, V., Joseph, S., Ahmed, N.

Get full text

1062 - Immunotherapy: MODULATION OF CD6 SPLICE VARIANTS CONTROLS CAR T CELL ACTIVATION by Morris, J., Gad, A.Z., Godret-Miertschin, L., Fleischmann, R., Salsman, V., Joseph, S., Ahmed, N.

Get full text

ANTI-TUMOR ACTIVITY OF ENDOGLIN CAR T CELLS AGAINST ADVANCED SARCOMAS by Joseph, S.K., Berger, H.R., Maharana, M., Kurenbekova, L., Delaidelli, A., Malik, S., Dasgupta, A., Ozcan, A.I., Morris, J., Gad, A.Z., Seon, B.K., McKenna, M., Sorensen, P.M., Hegde, M., Yustein, J.T., Ahmed, N.

“…The prognosis for metastatic sarcoma in children remains bleak. Cellular immunotherapy with chimeric antigen receptor T cells (CAR-T) can be a suitable…”
Get full text

Immunotherapy: SIGNALING DOMAINS, 41BB AND CD28, MEDIATE DISTINCT MOLECULAR DYNAMICS AT THE IMMUNE SYNAPSE THAT INFLUENCE CAR T CELL KILLING BEHAVIOR by Gad, A.Z., Morris, J.S., Godret-Miertschin, L., Montalvo, M.J., Fousek, K., Saeedi, A., Levental, K., Mamonkin, M., Carisey, A., Joseph, S., Hegde, M., Varadarajan, N., Levental, I., Mukherjee, M., Ahmed, N.

Get full text